Literature DB >> 130650

The nature and incidence of cryoproteins in hepatitis B antigen (HbsAg) positive patients.

R M Mcintosh, M N Koss, K J Gocke.   

Abstract

Hepatitis B (HbsAg) surface antigen has been detected in the serum of patients with a variety of diseases and immune complexes of this antigen and antibody have been implicated in tissue damage to various organs. Previously we have demonstrated that serum cryoproteins occur in a variety of immune complex disorders and represent pathogenic complexes of antigen and specific antibody. Sera from patients with acute HbsAg positive hepatitis, chronic hepatitis B antigenemia, acute and chronic HbsAg negative hepatitis, as well as a variety HbsAg negative miscellaneous liver diseases and normals were studied for the presence and nature of cryoproteins. Cryoproteins were detected in a large number of patients with acute and chronic HbsAg positive hepatitis and chronic HbsAg carriers. The quantity of these cold insoluble precipitates was highest in acute hepatitis. Cryoproteins were detected with much less frequency in HbsAg negative patients and were not found in normals. The precipitates in HbsAg patients contained either HbsAg, anti-HBsAg or both, along with immunoglobulins and occasionally complement and rheumatoid factor. The cryoproteins in these patients had biological properties attributable to immune complexes and several of the patients had clinical manifestations of acute or chronic serum sickness. Cryoproteins from HbsAg negative patients did not contain HbsAg or antibody to HbsAg and did not have biologic properties of immune complexes. In HbsAg positive patients HbsAg and antibody to HbsAg were concentrated in the cryoprecipitate. The preliminary studies suggest that investigation on cryoproteins in hepatitis may be of clinical and immunopathogenic value.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 130650

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  13 in total

Review 1.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

Review 2.  The kidney in mixed cryoglobulinemias.

Authors:  D J Cordonnier; J C Renversez; P Vialtel; E Dechelette
Journal:  Springer Semin Immunopathol       Date:  1987

Review 3.  Immunopathogenesis of the extrahepatic manifestations of hepatitis B virus infection.

Authors:  J L Dienstag
Journal:  Springer Semin Immunopathol       Date:  1981-04

4.  HBsAg immune complexes in the course of infection with hepatitis B virus.

Authors:  K Madaliński; I Bragiel
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

5.  Arthritis and hepatitis.

Authors:  R T Mirise; R C Kitridou
Journal:  West J Med       Date:  1979-01

6.  Status of hepatitis B virus in the aetiology of uveitis in Great Britain.

Authors:  P I Murray; J Prasad; A H Rahi
Journal:  Br J Ophthalmol       Date:  1983-10       Impact factor: 4.638

7.  Studies on circulating soluble immune complexes of the liver disease. 6. Comparative studies of 125I-pRF inhibition assay, 125I-Clq inhibition assay and 125I-Clq binding assay.

Authors:  J Narumoto
Journal:  Gastroenterol Jpn       Date:  1981

8.  Cryoglobulinemia in acute type-A hepatitis.

Authors:  M Shalit; S Wollner; Y Levo
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

9.  Long-term results regarding the use of recombinant interferon alpha-2b in the treatment of II type mixed essential cryoglobulinemia.

Authors:  V M Lauta; M A De Sangro
Journal:  Med Oncol       Date:  1995-12       Impact factor: 3.064

10.  Cryoimmunoglobulinaemia in patients with renal disease. II attempts to demonstrate-that cryoprecipitate contain autoantibodies and/or antigen.

Authors:  J J McPhaul; R Montgomery
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.